Literature DB >> 24236248

Safety and Feasibility of Topical Application of Limonene as a Massage Oil to the Breast.

Jessica A Miller1, Patricia A Thompson, Iman A Hakim, Ana Maria Lopez, Cynthia A Thomson, Wade Chew, Chiu-Hsieh Hsu, H-H Sherry Chow.   

Abstract

BACKGROUND: Limonene, a major component in citrus oil, has demonstrated anti-cancer effects in preclinical mammary cancer models. However, the effective oral dose translates to a human dose that may not be feasible for chronic dosing. We proposed to evaluate topical application of limonene to the breast as an alternative dosing strategy.
MATERIALS AND METHODS: We conducted a mouse disposition study to determine whether limonene would be bio available in the mammary tissue after topical application. SKH-1 mice received topical or oral administration of limonene in the form of orange oil every day for 4 weeks. Plasma and mammary pads were collected 4 hrs after the final dosing. We also conducted an exploratory clinical study to evaluate the safety and feasibility of topically applied limonene in the form of orange oil to the breast. Healthy women were recruited to apply orange oil containing massage oil to their breasts daily for four weeks. Safety and feasibility were assessed by reported adverse events, clinical labs, and usage compliance. Pre and post-intervention nipple aspirate fluid (NAF) and plasma were collected for limonene concentration determination.
RESULTS: The mouse disposition study showed that topical and oral orange oil administration resulted in similar mammary tissue disposition of limonene with no clinical signs of toxicity. In the clinical study, the topical application of limonene containing massage oil to the breast was found to be safe with high levels of usage compliance for daily application, although NAF and plasma limonene concentrations were not significantly changed after the massage oil application.
CONCLUSIONS: Our studies showed that limonene is bio available in mammary tissue after topical orange oil application in mice and this novel route of administration to the breast is safe and feasible in healthy women.

Entities:  

Keywords:  Limonene; Safety; Topical Application

Year:  2012        PMID: 24236248      PMCID: PMC3824622          DOI: 10.4236/jct.2012.325094

Source DB:  PubMed          Journal:  J Cancer Ther        ISSN: 2151-1934


  19 in total

1.  Mechanism(s) of in vitro percutaneous absorption enhancement of tamoxifen by enhancers.

Authors:  K Zhao; J Singh
Journal:  J Pharm Sci       Date:  2000-06       Impact factor: 3.534

2.  The prevention of nitrosomethylurea-induced mammary tumors by d-limonene and orange oil.

Authors:  T H Maltzman; L M Hurt; C E Elson; M A Tanner; M N Gould
Journal:  Carcinogenesis       Date:  1989-04       Impact factor: 4.944

3.  Neoadjuvant percutaneous 4-hydroxytamoxifen decreases breast tumoral cell proliferation: a prospective controlled randomized study comparing three doses of 4-hydroxytamoxifen gel to oral tamoxifen.

Authors:  Philippe Rouanet; Gustavo Linares-Cruz; François Dravet; Sylvain Poujol; Sophie Gourgou; Joelle Simony-Lafontaine; Jean Grenier; Andrew Kramar; Jean Girault; Elisabeth Le Nestour; Thierry Maudelonde
Journal:  J Clin Oncol       Date:  2005-05-01       Impact factor: 44.544

4.  Adipose tissue accumulation of d-limonene with the consumption of a lemonade preparation rich in d-limonene content.

Authors:  Jessica A Miller; Iman A Hakim; Wade Chew; Patricia Thompson; Cynthia A Thomson; H-H Sherry Chow
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

5.  Contact allergens and irritants in household washing and cleaning products.

Authors:  Michela Magnano; Simonetta Silvani; Colombina Vincenzi; Massimiliano Nino; Antonella Tosti
Journal:  Contact Dermatitis       Date:  2009-12       Impact factor: 6.600

6.  Determination of d-limonene in adipose tissue by gas chromatography-mass spectrometry.

Authors:  Jessica A Miller; Iman A Hakim; Cynthia Thomson; Patricia Thompson; H-H Sherry Chow
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-06-06       Impact factor: 3.205

7.  MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation.

Authors:  Joyce A Schroeder; Azzah Al Masri; Melissa C Adriance; Jennifer C Tessier; Kari L Kotlarczyk; Melissa C Thompson; Sandra J Gendler
Journal:  Oncogene       Date:  2004-07-29       Impact factor: 9.867

8.  Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.

Authors:  M N Gould; C J Moore; R Zhang; B Wang; W S Kennan; J D Haag
Journal:  Cancer Res       Date:  1994-07-01       Impact factor: 12.701

9.  Anti-carcinogenic activity of d-limonene during the initiation and promotion/progression stages of DMBA-induced rat mammary carcinogenesis.

Authors:  C E Elson; T H Maltzman; J L Boston; M A Tanner; M N Gould
Journal:  Carcinogenesis       Date:  1988-02       Impact factor: 4.944

10.  Patch testing with oxidized R-(+)-limonene and its hydroperoxide fraction.

Authors:  Mihály Matura; An Goossens; Olivia Bordalo; Begoña Garcia-Bravo; Kerstin Magnusson; Karin Wrangsjö; Ann-Therese Karlberg
Journal:  Contact Dermatitis       Date:  2003-07       Impact factor: 6.600

View more
  5 in total

1.  Plasma metabolomic profiles of breast cancer patients after short-term limonene intervention.

Authors:  Jessica A Miller; Kirk Pappan; Patricia A Thompson; Elizabeth J Want; Alexandros P Siskos; Hector C Keun; Jacob Wulff; Chengcheng Hu; Julie E Lang; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2014-11-11

2.  Metabolomic characterization of nipple aspirate fluid by (1)H NMR spectroscopy and GC-MS.

Authors:  Gregory D Tredwell; Jessica A Miller; H-H Sherry Chow; Patricia A Thompson; Hector C Keun
Journal:  J Proteome Res       Date:  2014-01-07       Impact factor: 4.466

3.  Human breast tissue disposition and bioactivity of limonene in women with early-stage breast cancer.

Authors:  Jessica A Miller; Julie E Lang; Michele Ley; Ray Nagle; Chiu-Hsieh Hsu; Patricia A Thompson; Catherine Cordova; Amy Waer; H-H Sherry Chow
Journal:  Cancer Prev Res (Phila)       Date:  2013-04-03

4.  Expression of epidermal growth factor, transforming growth factor-β1 and adiponectin in nipple aspirate fluid and plasma of pre and post-menopausal women.

Authors:  Jessica A Miller; Patricia A Thompson; Iman A Hakim; Ana Maria Lopez; Cynthia A Thomson; Chiu-Hsieh Hsu; H-H Sherry Chow
Journal:  Biomark Res       Date:  2013-04-15

5.  Transpapillary drug delivery to the breast.

Authors:  Kaushalkumar Dave; Ranjith Averineni; Preety Sahdev; Omathanu Perumal
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.